In the days of the Armada, a fleet of warships, the scuttlebutt was the rumor or gossip that would spread throughout the ship. Today, Armada Law Corp presents The Scuttlebutt, a daily summery of news articles that people within the cannabis, hemp and plant medicine industries are chatting about along with links to the full articles.
In today’s news:
Washington State Marijuana Drug Testing Law Takes Effect January 2024
#cannabispolitics – “On January 1, 2024, Senate Bill 5132 (SB 5132) will take effect and provide protections for adult marijuana users in the State of Washington and impose limitations on employment drug testing related to cannabis. Employers in the Evergreen State who drug test must prepare to comply when the Act takes effect in 2024….”
DEA Threatens Georgia Pharmacies Over Dispensing Medical Marijuana Under State Law
#cannabislaw – “Georgia recently became the first U.S. state to allow pharmacies to sell medical marijuana, with nearly 120 facilities applying to sell cannabis oil as of October. But now the federal Drug Enforcement Administration (DEA) is warning pharmacies that dispensing THC is unlawful because it remains a Schedule I drug.
“All DEA registrants, including DEA-registered pharmacies, are required to abide by all relevant federal laws and regulations,” says a copy of a letter sent to a Georgia pharmacy by Matthew J. Strait, a DEA deputy assistant administrator in the agency’s Diversion Control Division. “A DEA-registered pharmacy may only dispense controlled substances in Schedules II-V of the Controlled Substances Act. Neither marijuana nor THC can lawfully be possessed, handled, or dispensed by any DEA-registered pharmacy.””
Curaleaf Exits Vermont Market in Sell-Off to Social Equity Operator
#cannabisindustry – “Curaleaf is leaving yet another state market.
The largest publicly traded cannabis company in the nation by market cap, the New York-based multistate operator sold off its vertical assets in Vermont, according to Vermont Business Magazine and VT Digger.
Zenbarn Ventures Inc., a social equity operator doing business as Zenbarn Farms with a dispensary in Waterbury, Vt., reported Dec. 1 that it had acquired Curaleaf’s Vermont assets, including a Vermont Patients Alliance dispensary in Bennington and a PhytoCare Vermont dispensary in Montpelier, as well as a greenhouse cultivation and manufacturing facility, according to Vermont Business….”
Alabama Pot Company Sues Regulators Over Rescinded License | Shocking Story of Injustice
Cannabis And Psychosis Are Linked, And This Could Be Why
#cannabisresearch – “According to a 2021 study conducted by a team of researchers from the Centre for Addiction and Mental Health (CAMH) and King’s College London in the UK, the genes for schizophrenia could prove to be the key to explaining why some cannabis users develop psychosis while others don’t.
“These results are significant because they’re the first evidence we’ve seen that people genetically prone to psychosis might be disproportionately affected by cannabis,” said CAMH psychiatrist Michael Wainberg when the findings were published….”
Psychedelic productivity: Can microdosing psilocybin boost your performance at work?
#psychedelics – ““I used to be a banker and venture capitalist so my mental health was very, very bad, and it got even worse during the pandemic,” Van de Plassche said.
After suffering from workplace stress, anxiety, and depression, Van de Plassche says she started looking into microdosing. She said it changed her life.
“Being able to alleviate the mental pain from stress, anxiety, and depression has really opened up a different life for me,” Van de De Plassche said.
She noticed that there wasn’t just a change in her happiness, her performance at work also improved….”